Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
Condition:   Acromegaly Intervention:   Sponsor:   Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2019 Category: Research Source Type: clinical trials

Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
Condition:   Acromegaly Interventions:   Drug: IONIS GHR-LRx;   Drug: SRL Sponsor:   Ionis Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2019 Category: Research Source Type: clinical trials